August 6, 2014  

    The treatment of two Ebola-infected Americans with an experimental drug, Z-Mapp, raises the question of whether it has potential for widespread use in combating the outbreak in West Africa. Judy Woodruff gets perspective on the topic from two experts, Dr. Robert Garry of Tulane University School of Medicine and Laurie Garrett of the Council on Foreign Relations. Continue reading

  • Emory Hospital To Receive American Ebola Patients From Liberia
    August 6, 2014  

    Two Americans infected with the Ebola virus and being treated in Atlanta have received an experimental drug, Z-Mapp, that had not previously been tested on humans and is in extremely limited supply. The WHO announced the latest numbers in rising death toll from the outbreak and said it is convening a medical panel to consider the ethics of making the drug more widely available. Judy Woodruff reports. Continue reading

  • April 26, 2010  

    NewsHour analyst Susan Dentzer, editor-in-chief of Health Affairs, moderated a Miller Center of Public Affairs debate on the ethics of rationing end-of-life health care after the issue gained prominence in the health care reform discussions. Here’s an excerpt: Continue reading

  • November 20, 2007  

    Scientists reported Tuesday that they had succeeded in making human skin cells mimic embroynic stem cells, potentially bypassing the ethical debate over embryonic stem cell use. A cell biologist discusses the research behind the advance. Continue reading

  • August 24, 2006  

    Scientists have announced a new method of extracting stem cells from embryos, but it has done little to quell ethical concerns about the research. Two experts debate the ramifications of the new procedure. Continue reading